Raymond James Financial Services Advisors’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$978K Buy
41,119
+5,383
+15% +$129K ﹤0.01% 2182
2024
Q2
$813K Buy
35,736
+4,407
+14% +$96.3K ﹤0.01% 2210
2024
Q1
$695K Buy
31,329
+3,078
+11% +$68.2K ﹤0.01% 2282
2023
Q4
$618K Sell
28,251
-349
-1% -$6.87K ﹤0.01% 2275
2023
Q3
$567K Sell
28,600
-494
-2% -$10.1K ﹤0.01% 2249
2023
Q2
$594K Sell
29,094
-272
-0.9% -$5.69K ﹤0.01% 2243
2023
Q1
$608K Hold
29,366
﹤0.01% 2208
2022
Q4
$619K Buy
29,366
+4,093
+16% +$84.6K ﹤0.01% 2141
2022
Q3
$478K Buy
+25,273
New +$502K ﹤0.01% 2275

Other funds holding IBBQ

Raymond James Financial Services Advisors's IBBQ Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 15% in Q3 2024, buying an estimated $129K and bringing the position to 41,119 shares worth $978K. The position accounts for ﹤0.01% of the portfolio, ranked #2182.

Raymond James Financial Services Advisors first reported a position in IBBQ in Q3 2022 and has held it in 9 quarters since. 22 funds tracked by Wall St. Rank hold IBBQ as of Q3 2024.

  • Raymond James Financial Services Advisors held 41,119 shares of Invesco NASDAQ Biotechnology ETF worth $978K as of Q3 2024.
  • Raymond James Financial Services Advisors bought 5,383 Invesco NASDAQ Biotechnology ETF shares in Q3 2024, an estimated $129K.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2182 holding.
  • Raymond James Financial Services Advisors first reported a position in Invesco NASDAQ Biotechnology ETF in Q3 2022 and has held it in 9 quarters since.
  • 22 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.